Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2021 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year
Filters applied: . Clear all Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Showing results for Mary L. galazka
Your search for Mary L. Galaska retrieved no results
Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis.
Cook S, Leist T, Comi G, Montalban X, Giovannoni G, Nolting A, Hicking C, Galazka A, Sylvester E. Cook S, et al. Mult Scler Relat Disord. 2019 Apr;29:157-167. doi: 10.1016/j.msard.2018.11.021. Epub 2018 Nov 20. Mult Scler Relat Disord. 2019. PMID: 30885374 Free article.
In general there was no increase in the risk of infections including opportunistic infections with cladribine tablets versus placebo, except for herpes zoster. Periods of severe lymphopenia (< 0.5 10(9) cells/L) were associated with an increased frequency of infections, …
In general there was no increase in the risk of infections including opportunistic infections with cladribine tablets versus placebo, except …